(ATDN) Insulin-like Growth Factor

(ATDN) Insulin-like Growth Factor

Treatment Review #15; December 1994

Insulin-like growth factor (IGF-1) is produced by the liver in response to human growth hormone. Many of growth hormone's effects may be the result of IGF-1. Human growth hormone is described in the article on serostim on page 3. A trial comparing growth hormone and IGF-1 for the treatment of children and adolescents with HIV infection is being conducted at the National Cancer Institute. To participate in this trial, you must be 6 to 18 years old with a failure to grow or less than normal weight or height. Participants will be divided into two groups. One group will be given IGF-1 twice a day. The second group will be given human growth hormone once a day. Both treatments are given by shot. Participants being given IGF-1 will have to be in the hospital for five days. Total time on study is 6 months.

941201
ATR01515

Always watch for outdated information. This article first appeard in 1994. This material is designed to support, not replace, the relationship that exists between you and your doctor.

Copyright © 1994 - AIDS Treatment Data Network. If you want to copy, reproduce or excerpt this information, please give us a call at (800) 734-7104. This helps up to keep track of where and how this information is being used. You can also Email us at network@atdn.org http://206.179.124.69/network/index.html

This information is designed to support, not replace, the relationship that exists between you and your doctor.
©1994. AEGIS.